Cantor Fitzgerald kicked off coverage of Merck with a neutral rating and a price target of $85, triggering a chorus of ...

Cantor Fitzgerald initiated coverage on Pfizer, giving a neutral rating and a $24 target price. Despite recent analyst ...

President Donald Trump continues to fuel the cryptocurrency industry, sparking major investments that are enriching his ...

Some of Trump’s policy shifts align with his advisers’ financial interests, setting up potential conflicts of interest.

The chair of the brokerage company Cantor Fitzgerald is reportedly creating a consortium with SoftBank, Tether and Bitfinex ...

The investment giant behind WeWork isn’t afraid to make big, questionable-seeming bets. At the very least, though, SoftBank ...

US stocks gain midsday as earnings roll in. Alphabet, Google's parent, reports after the close. Market shrugs off data, China ...

Stablecoin issuer Tether's investment unit has boosted its stake in Juventus Football Club (JVTSF) to over 10.12%, giving it ...

Bitcoin price continues rally as spot bitcoin ETF flows nearly hit $1B. Cantor, SoftBank plot new crypto venture to buy ...

Potential funding cuts for NOAA and its research partners threaten irreparable harm not only to climate research but to American safety, competitiveness, and national security.

A new Bitcoin (CRYPTO: BTC)-centric public company, Twenty One, is set to launch through a SPAC merger with Cantor Equity ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Amgen (AMGN – Research Report), with a price target of ...